What is the best country for stem cell therapy for ALS (Motor Neurone Disease)?
There is no evidence-based best-country ranking for ALS cell therapy. Prioritise a prospectively registered, regulator-authorised trial with a named sponsor, independent ethics review, defined manufacturing controls, ALS subspecialty and respiratory expertise, prespecified functional and survival endpoints and a public results plan. Claimed cohort size, rapid enrolment and destination pricing are not substitutes for evidence.
The cost picture for ALS (Motor Neurone Disease)
Private investigational ALS cell procedures can involve separate charges for intrathecal administration, neurological and respiratory assessment, imaging, monitoring, travel and treatment of complications. Prices do not indicate regulatory approval or expected benefit, and repeat dosing is not an established standard. Patients should request an itemised written quote and verify sponsor, insurer and patient responsibilities. Multidisciplinary ALS care and approved or guideline-supported treatment must not be delayed.
Am I a candidate? → · ALS (Motor Neurone Disease): full overview → · ALS (Motor Neurone Disease) cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- ALS (Motor Neurone Disease): cell-therapy evidence and registered trials
- How much does stem cell therapy for ALS (Motor Neurone Disease) cost? (2026)
- ALS (Motor Neurone Disease) stem cell therapy — your questions answered (2026)
- ALS (Motor Neurone Disease): cell-therapy evidence by therapy class
- MSC vs HSCT for ALS (Motor Neurone Disease): what the registries show